Cumberland Pharmaceuticals’ Duchenne muscular dystrophy (DMD) drug has improved the amount of blood pumped by the heart, hitting the main goal of a phase 2 trial. The active thromboxane receptor ...
*The main analyses of ambulatory BP endpoints include patients with valid ambulatory blood pressure monitoring at both baseline and Week 12, without imputation of missing data. The Phase III Bax24 ...
A new drug may help people with high blood pressure that does not respond to existing medications. The results of a large clinical trial, published August 30 in the New England Journal of Medicine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results